Overview

Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
A randomised, double-blind, placebo-controlled trial to evaluate the role of intracoronary injection of progenitor cells compared to placebo injection in patients with Dilated Cardiomyopathy who have been pre-treated with G-CSF (Granocyte™) injections for 5 days, and patients treated with a 5 day course of G-CSF (Granocyte™) injection only compared to placebo injection
Phase:
Phase 2
Details
Lead Sponsor:
Barts & The London NHS Trust
Collaborators:
Royal Brompton & Harefield NHS Foundation Trust
University College London Hospitals
Treatments:
Lenograstim
Sargramostim